Skip to content

Harm-reduction information only — not medical advice. In crisis or experiencing adverse effects, contact a healthcare professional or your local emergency services immediately.

AnabolicDex logo AnabolicDex
Search (no-JS fallback)

Semaglutide Titration (20 weeks)

FDA Wegovy label titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly, escalating every 4 weeks to the 2.4mg maintenance dose.

Concentration over time

Concentration values over time. Rows are sampled dates; columns are compounds.
DateSemaglutide Injection (Ozempic/Wegovy)
W10.00
W21534.89
W42407.65
W62318.63
W73738.00
W97672.34
W115462.51
W127713.84
W1415587.04
W1610019.31
W1716240.32
W1923547.03
W2114589.37

Protocol summary

Semaglutide Titration (20 weeks) · 20 weeks starting Jul 20, 26

  • Semaglutide Injection (Ozempic/Wegovy) — 250 mcg Every 7 days, weeks 0–3
  • Semaglutide Injection (Ozempic/Wegovy) — 500 mcg Every 7 days, weeks 4–7
  • Semaglutide Injection (Ozempic/Wegovy) — 1.00 mg Every 7 days, weeks 8–11
  • Semaglutide Injection (Ozempic/Wegovy) — 1.70 mg Every 7 days, weeks 12–15
  • Semaglutide Injection (Ozempic/Wegovy) — 2.40 mg Every 7 days, weeks 16–20

Protocol overview

Category
weightloss
Duration
20 weeks
Compounds
5
Tags
glp-1, weightloss, semaglutide, titration

Compounds in this protocol

How to read this protocol

The chart above shows the modeled blood concentration of each compound over the 20-week duration. Each compound accumulates toward steady state (roughly 5 half-lives). The peak-to-trough ratio within each dose interval depends on the injection frequency relative to the half-life.

Use the [peak-trough estimator](/tools/peak-trough) to see predicted levels at any point, or the [clearance calculator](/tools/clearance) to estimate washout after the protocol ends. The [PCT planner](/pct-planner) estimates when to start post-cycle therapy.

Educational only. Not medical advice. Concentration values are modeled estimates based on population pharmacokinetics, not predictions of individual blood levels.